DIVERSIFIED HEALTHCARE TRUST

DHC

$2.15B

Mid Cap

NASDAQReal Estate Investment Trusts🇺🇸North AmericaNEWTON

Drugs in Pipeline

Phase 3 Programs

Upcoming Catalysts

Next Catalyst

None scheduled

Market Overview

Stock performance and key metrics

DHC News

Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

How DHC's past catalysts played out

earningsNov 2025-8%earningsMar 2023-5%earningsMay 2020-6%earningsMar 2020+7%earningsNov 2019-10%earningsAug 2019+5%earningsMar 2019-9%earningsFeb 2018-6%

Drug Pipeline

No drugs found in this phase.

📑

Catalyst DossierPRO

The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.

→

Market-Implied Move

Regulatory Approvals

Frequently asked questions

When is DIVERSIFIED HEALTHCARE TRUST's next FDA catalyst?→

CatalystAlert tracks every upcoming catalyst for DIVERSIFIED HEALTHCARE TRUST (DHC) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.

How do I track DHC biotech catalysts?→

Add DHC to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow DIVERSIFIED HEALTHCARE TRUST's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply